US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 1.600
  • -0.030-1.84%
Close May 2 16:00 ET
  • 1.630
  • +0.030+1.88%
Post 17:47 ET
66.47MMarket Cap-748P/E (TTM)

Carisma Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Carisma Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

4.29M

+14.96%
EPS(YoY)

-0.48

-15.43%
Analyst Rating

Strong Buy

Apr 30, 2024

Carisma Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 4.430M--
--2024/Q1-- / 4.396M--
--2023/Q44.289M / 2.907M--
--2023/Q33.827M / 890.000K--
--2023/Q23.560M / 3.243M--
--2023/Q13.243M / 3.731M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 4.430M--
--2024/Q1-- / 4.396M--
--2023/Q44.289M / 2.907M--
--2023/Q33.827M / 890.000K--
--2023/Q23.560M / 3.243M--
--2023/Q13.243M / 3.731M--
--------
--------
--------
--------

Unlock Free Earnings Estimates

Carisma Therapeutics Earnings Reports

  • Carisma Therapeutics | 10-K: Annual report

    Apr 1 08:51 ET

  • Carisma Therapeutics | 10-Q: Quarterly report

    Nov 9, 2023 08:36 ET

  • Carisma Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 08:36 ET

  • Carisma Therapeutics | 10-Q: Quarterly report

    May 11, 2023 08:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg